AstraZeneca PLC (AZN :)

LATEST ABOUT THIS TOPIC ON CNBC.COM

• More

• Immune system cancer drugs tipped to be a $35 bln market 30 mins ago - Reuters
• AstraZeneca closes in on site for new home in Cambridge 20 May 2013 - Reuters
• Impax Labs launches generic version of Zomig 17 May 2013 - The Associated Press
• UPDATE 1-Cubist bid for Optimer before sale process began-sources 15 May 2013 - Reuters
• RPT-ANALYSIS-Drugmakers face more scrutiny of discordant U.S. prices 10 May 2013 - Reuters
• Dentsply 1Q income rises, company cuts outlook 09 May 2013 - The Associated Press
• Drug Spending Drops for the First Time in 55 Years 09 May 2013 - Reuters
• European shares slip from multi-year highs 09 May 2013 - Reuters
• European shares dip from multi-year highs 09 May 2013 - Reuters
• U.S. spending on medicines fell for first time in 2012 08 May 2013 - Reuters

MORE FROM CNBC

• More

• Stocks End Off Highs, but S&P, Nasdaq Log Gains for 5th Day 25 Apr 2013 - CNBC.com
• Europe Closes Up on Upbeat UK GDP 25 Apr 2013 - CNBC.com
• Futures Edge Higher on Earnings, Jobless Claims; 3M Slumps 25 Apr 2013 - CNBC.com

MORE FROM OUR PARTNERS

• More

• AstraZeneca: A Dividend Payer With An Attractive Growth Prospect 20 May 2013 - Seeking Alpha
• Array Biopharma: Measuring The Strength Of This Small-Cap Pharma Stock 15 May 2013 - Seeking Alpha
• What To Buy And Sell In Your High-Yield Portfolio 14 May 2013 - Seeking Alpha
• Wall Street Breakfast: Must-Know News 14 May 2013 - Seeking Alpha
• Part 2: Will Array BioPharma Become A Late-Stage Biopharmaceutical Com... 12 May 2013 - Seeking Alpha
• Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Com... 12 May 2013 - Seeking Alpha
• 6 Superstars For Your Biotech Portfolio: John McCamant 10 May 2013 - Seeking Alpha
• Cellceutix Corporation: The Next Generation Of Cancer Treatment Has Ar... 09 May 2013 - Seeking Alpha
• Pounding The Table On Pozen: Why There's Upside In This Misunderstood ... 08 May 2013 - Seeking Alpha
• What Is Due Diligence For (Exponential) Dividend Growth Stocks? 06 May 2013 - Seeking Alpha

LATEST TRANSCRIPTS

• More

• AstraZeneca's CEO Discusses Q1 2013 Results - Earnings Call Transcript 26 Apr 2013 - Seeking Alpha

PRESS RELEASES

• More

• CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013 6 hrs ago - Business Wire
• Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference 13 hrs ago - PR Newswire
• Red Cross Helping Oklahoma Tornado Victims With Shelter, Food, Relief ... 17 hrs ago - PR Newswire
• Results from Phase III Studies of Naloxegol for Treatment of Opioid-In... 20 hrs ago - Business Wire
• KineMed Announces an Agreement With MedImmune to Study Protein Dynamic... 22 hrs ago - Business Wire
• Presence of Gastric Erosions in Patients Taking Low-Dose Aspirin for S... 22 hrs ago - Business Wire
• Research and Markets: BioPharmaceutical Industry in China - 2013 Analy... 20 May 2013 - Business Wire
• Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cas... 20 May 2013 - PR Newswire
• Research and Markets: Global Vaccine Market Forecast to 2017 20 May 2013 - Business Wire
• Zogenix and Battelle to Present Positive, New Data Demonstrating Value... 20 May 2013 - Globe Newswire

• 

  Top 50 Hedge Funds Ditch News Corp for Boeing

• Property Drives Wealth of China's Richest Women
• Tax Evasion Dangerous for Europe: Schulz
• Move Into 'Junk' Stocks Powers Bull Run
• Oklahoma: Where Financial Relief Will Come From
• Kids Turn to Twitter, Shun Facebook 'Drama'
• EU Bank Bonuses to Affect a Lot More Bankers
• Sony to Assess Loeb Spin-Off Plan; Cuts Targets
• BlackBerry Now Aims to Run Smartphone World
• Why Can't Shell Find 'Capable Women'?  

• Download Free Annual Report.